Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
Kang, C., Bernaldez, M., Stamatis, S
European journal of pharmacology , 660 (1), 1320
Semaglutide has the strongest cardiovascular outcomes data in people with obesity without diabetes
GLP-1 medications work in part by slowing down stomach emptying, leading to increased feelings of fullness
"Eriomin's ability to naturally activate GLP-1 pathways makes it an ideal fit for today's consumer seeking effective and evidence-based metabolic support." Doug Lynch, Founder of MarketWell Nutrition and Commercial Lead for Ingredients by Nature, added, "Non-pharmaceutical cardio-metabolic actives that are natural GLP-1 boosters are in high demand, but unlike Eriomin, typically fall short on human clinical substantiation and Intellectual Property
